Evidence map›Paper›PMID 38023505›Full record

ArticleChemical science2023

Stereoselective RNA reaction with chiral 2'-OH acylating agents.

Ryuta Shioi, Lu Xiao, Sayantan Chatterjee, Eric T Kool

Abstract read
In one paragraph

Article in Chemical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Fluorogenic Covalent Probes for RNA.Journal of the American Chemical Society · 2025
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ryuta ShioiDepartment of Chemistry, Stanford University Stanford CA 94305 USA kool@stanford.edu.
Lu XiaoDepartment of Chemistry, Stanford University Stanford CA 94305 USA kool@stanford.edu.ORCID https://orcid.org/0000-0003-1934-4711
Sayantan ChatterjeeDepartment of Chemistry, Stanford University Stanford CA 94305 USA kool@stanford.edu.ORCID https://orcid.org/0000-0001-9265-595X
Eric T KoolDepartment of Chemistry, Stanford University Stanford CA 94305 USA kool@stanford.edu.ORCID https://orcid.org/0000-0002-7310-2935

Funding

Transcriptome Analysis with RNA-Reactive ProbesR35GM145357 · NIGMS · STANFORD UNIVERSITY · PI ERIC T. KOOL · 2022 to 2026
$3.0M
Probing the Transcriptome with Multifunctional Acylation ChemistryR01GM127295 · NIGMS · STANFORD UNIVERSITY · PI KOOL, ERIC T. · 2018 to 2021
$1.3M
NIGMS NIH HHS R01 GM127295NIGMS NIH HHS R35 GM145357
6 · The paper itself

Abstract

The reactivity of RNA 2'-OH groups with acylating agents has recently been investigated for high-yield conjugation of RNA strands. To date, only achiral molecules have been studied for this reaction, despite the complex chiral structure of RNA. Here we prepare a set of chiral acylimidazoles and study their stereoselectivity in RNA reactions. Reactions performed with unfolded and folded RNAs reveal that positional selectivity and reactivity vary widely with local RNA macro-chirality. We further document remarkable effects of chirality on reagent reactivity, identifying an asymmetric reagent with 1000-fold greater reactivity than prior achiral reagents. In addition, we identify a chiral compound with higher RNA structural selectivity than any previously reported RNA-mapping species. Further, azide-containing homologs of a chiral dimethylalanine reagent were synthesized and applied to local RNA labeling, displaying 92% yield and 16 : 1 diastereoselectivity. The results establish that reagent stereochemistry and chiral RNA structure are critical elements of small molecule-RNA reactions, and demonstrate new chemical strategies for selective RNA modification and probing.

Identifiers

PMID38023505
PMCPMC10664579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.